cached image

Philip Scheltens, MD PhD - Related publications

Affiliations: 
Alzheimer Center VU University Medical Center, Amsterdam, Netherlands 
Area:
dementia, MRI, CSF, PET, http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=111
Website:
https://www.knaw.nl/nl/leden/leden/11669
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Herring WL, Gould IG, Fillit H, Lindgren P, Forrestal F, Thompson R, Pemberton-Ross P. Predicted Lifetime Health Outcomes for Aducanumab in Patients with Early Alzheimer's Disease. Neurology and Therapy. PMID 34426940 DOI: 10.1007/s40120-021-00273-0   
2021 Iida MA, Farrell K, Walker JM, Richardson TE, Marx GA, Bryce CH, Purohit D, Ayalon G, Beach TG, Bigio EH, Cortes EP, Gearing M, Haroutunian V, McMillan CT, Lee EB, et al. Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study. Acta Neuropathologica Communications. 9: 134. PMID 34353357 DOI: 10.1186/s40478-021-01233-3   
2021 Chen W, Li S, Ma Y, Lv S, Wu F, Du J, Wu H, Wang S, Zhao Q. A simple nomogram prediction model to identify relatively young patients with mild cognitive impairment who may progress to Alzheimer's disease. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 91: 62-68. PMID 34373060 DOI: 10.1016/j.jocn.2021.06.026   
2021 Liu Z, Li H, Pan S. Discovery and Validation of Key Biomarkers Based on Immune Infiltrates in Alzheimer's Disease. Frontiers in Genetics. 12: 658323. PMID 34276768 DOI: 10.3389/fgene.2021.658323   
2021 Wang H, Han X, Gao S. Identification of potential biomarkers for pathogenesis of Alzheimer's disease. Hereditas. 158: 23. PMID 34225819 DOI: 10.1186/s41065-021-00187-9   
2021 Kalaria RN, Sepulveda-Falla D. Cerebral Small Vessel Disease in Sporadic and Familial Alzheimer Disease. The American Journal of Pathology. PMID 34331941 DOI: 10.1016/j.ajpath.2021.07.004   
2021 van de Mortel LA, Thomas RM, van Wingen GA, . Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 34366336 DOI: 10.3233/JAD-210173   
2021 Kim S, Nam Y, Ham MJ, Park C, Moon M, Yoo DH. Neurological Mechanisms of Animal-Assisted Intervention in Alzheimer's Disease: A Hypothetical Review. Frontiers in Aging Neuroscience. 13: 682308. PMID 34335229 DOI: 10.3389/fnagi.2021.682308   
2021 Xia N, Li Y, Xue Y, Li W, Zhang Z, Wen C, Li J, Ye Q. Intravoxel incoherent motion diffusion-weighted imaging in the characterization of Alzheimer's disease. Brain Imaging and Behavior. PMID 34480258 DOI: 10.1007/s11682-021-00538-0   
2021 Siafarikas N, Alnæs D, Monereo-Sanchez J, Lund MJ, Selbaek G, Stylianou-Korsnes M, Persson K, Barca ML, Almdahl IS, Fladby T, Aarsland D, Andreassen OA, Westlye LT. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia. International Psychogeriatrics. 1-12. PMID 34399870 DOI: 10.1017/S1041610221000934   
2021 das Neves SP, Taipa R, Marques F, Soares Costa P, Monárrez-Espino J, Palha JA, Kivipelto M. Association Between Iron-Related Protein Lipocalin 2 and Cognitive Impairment in Cerebrospinal Fluid and Serum. Frontiers in Aging Neuroscience. 13: 663837. PMID 34248600 DOI: 10.3389/fnagi.2021.663837   
2021 Fernandes M, Placidi F, Mercuri NB, Liguori C. The Importance of Diagnosing and the Clinical Potential of Treating Obstructive Sleep Apnea to Delay Mild Cognitive Impairment and Alzheimer's Disease: A Special Focus on Cognitive Performance. Journal of Alzheimer's Disease Reports. 5: 515-533. PMID 34368635 DOI: 10.3233/ADR-210004   
2021 Etminani K, Soliman A, Davidsson A, Chang JR, Martínez-Sanchis B, Byttner S, Camacho V, Bauckneht M, Stegeran R, Ressner M, Agudelo-Cifuentes M, Chincarini A, Brendel M, Rominger A, Bruffaerts R, et al. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34328531 DOI: 10.1007/s00259-021-05483-0   
2021 Zhang WT, Zhang GX, Gao SS. The potential diagnostic accuracy of circulating microRNAs for Alzheimer's disease: A meta-analysis. Neurologia (Barcelona, Spain). PMID 34301434 DOI: 10.1016/j.nrl.2021.06.001   
2021 Wei X, Xie L, Du P, Zhao Z. Impacts of DNA methylation on Tau protein related genes in the brains of patients with Alzheimer's Disease. Neuroscience Letters. 136196. PMID 34437990 DOI: 10.1016/j.neulet.2021.136196   
2021 Chiang TI, Yu YH, Lin CH, Lane HY. Novel Biomarkers of Alzheimer's Disease: Based Upon N-methyl-D-aspartate Receptor Hypoactivation and Oxidative Stress. Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 19: 423-433. PMID 34294612 DOI: 10.9758/cpn.2021.19.3.423   
2021 Chiang TI, Yu YH, Lin CH, Lane HY. Novel Biomarkers of Alzheimer's Disease: Based Upon N-methyl-D-aspartate Receptor Hypoactivation and Oxidative Stress. Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 19: 423-433. PMID 34294612 DOI: 10.9758/cpn.2021.19.3.423   
2021 He F, Li Y, Li C, Zhao J, Liu T, Fan L, Zhang X, Wang J. Changes in the connection network of whole-brain fiber tracts in patients with Alzheimer's disease have a tendency of lateralization. Neuroreport. PMID 34334777 DOI: 10.1097/WNR.0000000000001708   
2021 Güntekin B, Aktürk T, Arakaki X, Bonanni L, Del Percio C, Edelmayer R, Farina F, Ferri R, Hanoğlu L, Kumar S, Lizio R, Lopez S, Murphy B, Noce G, Randall F, et al. Are there consistent abnormalities in event-related EEG oscillations in patients with Alzheimer's disease compared to other diseases belonging to dementia? Psychophysiology. e13934. PMID 34460957 DOI: 10.1111/psyp.13934   
2021 Katzourou I, Leonenko G, Ivanov D, Meggy A, Marshall R, Sims R, Williams J, Holmans P, Escott-Price V, . Cognitive Decline in Alzheimer's Disease Is Not Associated with APOE. Journal of Alzheimer's Disease : Jad. PMID 34487047 DOI: 10.3233/JAD-210685   
2021 Siqueira LD, Celes APM, Dos Santos H, Ferreira ST. A Specialized Nutritional Formulation Prevents Hippocampal Glial Activation and Memory Impairment Induced by Amyloid-β Oligomers in Mice. Journal of Alzheimer's Disease : Jad. PMID 34397411 DOI: 10.3233/JAD-210139   
2021 Schindler S, Li Y, Buckles VD, Gordon BA, Benzinger TLS, Wang G, Coble D, Klunk WE, Fagan AM, Holtzman D, Bateman RJ, Morris JC, Xiong C. Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET. Neurology. PMID 34504028 DOI: 10.1212/WNL.0000000000012775   
2021 Pyun JM, Park YH, Lee KJ, Kim S, Saykin AJ, Nho K, . Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment. Translational Neurodegeneration. 10: 32. PMID 34465370 DOI: 10.1186/s40035-021-00259-w   
2021 Williams JB, Cao Q, Yan Z. Transcriptomic analysis of human brains with Alzheimer's disease reveals the altered expression of synaptic genes linked to cognitive deficits. Brain Communications. 3: fcab123. PMID 34423299 DOI: 10.1093/braincomms/fcab123   
2021 Lin RR, Xue YY, Li XY, Chen YH, Tao QQ, Wu ZY. Optimal Combinations of AT(N) Biomarkers to Determine Longitudinal Cognition in the Alzheimer's Disease. Frontiers in Aging Neuroscience. 13: 718959. PMID 34421579 DOI: 10.3389/fnagi.2021.718959   
2021 Wittens MMJ, Sima DM, Houbrechts R, Ribbens A, Niemantsverdriet E, Fransen E, Bastin C, Benoit F, Bergmans B, Bier JC, De Deyn PP, Deryck O, Hanseeuw B, Ivanoiu A, Lemper JC, et al. Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer's Disease in a Clinical Setting: A REMEMBER Study. Journal of Alzheimer's Disease : Jad. PMID 34334402 DOI: 10.3233/JAD-210450   
2021 Eikelboom WS, van den Berg E, Singleton EH, Baart SJ, Coesmans M, Leeuwis AE, Teunissen CE, van Berckel BNM, Pijnenburg YAL, Scheltens P, van der Flier WM, Ossenkoppele R, Papma JM. Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations. Neurology. PMID 34413181 DOI: 10.1212/WNL.0000000000012598   
2021 Kile S, Au W, Parise C, Rose K, Donnel T, Hankins A, Au Y, Chan M, Ghassemi A. Five-year outcomes after IVIG for mild cognitive impairment due to alzheimer disease. Bmc Neuroscience. 22: 49. PMID 34362303 DOI: 10.1186/s12868-021-00651-2   
2021 Zhang T, Liu N, Wei W, Zhang Z, Li H. Integrated Analysis of Weighted Gene Coexpression Network Analysis Identifying Six Genes as Novel Biomarkers for Alzheimer's Disease. Oxidative Medicine and Cellular Longevity. 2021: 9918498. PMID 34367470 DOI: 10.1155/2021/9918498   
2021 Liang PZ, Li L, Zhang YN, Shen Y, Zhang LL, Zhou J, Wang ZJ, Wang S, Yang S. Electroacupuncture Improves Clearance of Amyloid- through the Glymphatic System in the SAMP8 Mouse Model of Alzheimer's Disease. Neural Plasticity. 2021: 9960304. PMID 34484327 DOI: 10.1155/2021/9960304   
2021 Sanabria-Diaz G, Demonet JF, Rodriguez-Herreros B, Draganski B, Kherif F, Melie-Garcia L. Apolipoprotein E allele 4 effects on Single-Subject Gray Matter Networks in Mild Cognitive Impairment. Neuroimage. Clinical. 32: 102799. PMID 34469849 DOI: 10.1016/j.nicl.2021.102799   
2021 Fleming V, Piro-Gambetti B, Patrick A, Zammit M, Alexander A, Christian BT, Handen B, Cohen A, Klunk W, Laymon C, Ances BM, Plante DT, Okonkwo O, Hartley SL. Physical activity and cognitive and imaging biomarkers of Alzheimer's disease in down syndrome. Neurobiology of Aging. 107: 118-127. PMID 34428720 DOI: 10.1016/j.neurobiolaging.2021.07.016   
2021 Hojjati SH, Feiz F, Ozoria S, Razlighi QR, . Topographical Overlapping of the Amyloid-β and Tau Pathologies in the Default Mode Network Predicts Alzheimer's Disease with Higher Specificity. Journal of Alzheimer's Disease : Jad. PMID 34219729 DOI: 10.3233/JAD-210419   
2021 Yang P, Sun F. Aducanumab: The first targeted Alzheimer's therapy. Drug Discoveries & Therapeutics. 15: 166-168. PMID 34234067 DOI: 10.5582/ddt.2021.01061   
2021 Wu L, Du Q, Wu C. CircLPAR1/miR-212-3p/ZNF217 feedback loop promotes amyloid β-induced neuronal injury in Alzheimer's Disease. Brain Research. 1770: 147622. PMID 34403662 DOI: 10.1016/j.brainres.2021.147622   
2021 Brenowitz WD, Xiang Y, McEvoy CT, Yang C, Yaffe K, Le WD, Leng Y. Current Alzheimer disease research highlights: evidence for novel risk factors. Chinese Medical Journal. PMID 34507318 DOI: 10.1097/CM9.0000000000001706   
2021 Naudé PJW, Ramakers IHGB, van der Flier WM, Jiskoot LC, Reesink FE, Claassen JAHR, Koek HL, Eisel ULM, De Deyn PP. Serum and cerebrospinal fluid Neutrophil gelatinase-associated lipocalin (NGAL) levels as biomarkers for the conversion from mild cognitive impairment to Alzheimer's disease dementia. Neurobiology of Aging. 107: 1-10. PMID 34365256 DOI: 10.1016/j.neurobiolaging.2021.07.001   
2021 Wang H, Zhang Y, Zheng C, Yang S, Chen X, Wang H, Gao S. A 3-Gene-Based Diagnostic Signature in Alzheimer's Disease. European Neurology. 1-8. PMID 34521086 DOI: 10.1159/000518727   
2021 Li X, Yang C, Xie P, Han Y, Su R, Li Z, Liu Y. The diagnosis of amnestic mild cognitive impairment by combining the characteristics of brain functional network and support vector machine classifier. Journal of Neuroscience Methods. 109334. PMID 34428513 DOI: 10.1016/j.jneumeth.2021.109334   
2021 Sun RQ, Wang ZD, Zhao J, Wang S, Liu YZ, Liu SY, Li ZG, Wang X. Improvement of electroacupuncture on APP/PS1 transgenic mice in behavioral probably due to reducing deposition of Aβ in hippocampus. Anatomical Record (Hoboken, N.J. : 2007). PMID 34469051 DOI: 10.1002/ar.24737   
2021 Mank A, van Maurik IS, Bakker ED, van de Glind EMM, Jönsson L, Kramberger MG, Novak P, Diaz A, Gove D, Scheltens P, van der Flier WM, Visser LNC. Identifying relevant outcomes in the progression of Alzheimer's disease; what do patients and care partners want to know about prognosis? Alzheimer's & Dementia (New York, N. Y.). 7: e12189. PMID 34458555 DOI: 10.1002/trc2.12189   
2021 Gonneaud J, Baria AT, Pichet Binette A, Gordon BA, Chhatwal JP, Cruchaga C, Jucker M, Levin J, Salloway S, Farlow M, Gauthier S, Benzinger TLS, Morris JC, Bateman RJ, Breitner JCS, ... , ... , ... , et al. Accelerated functional brain aging in pre-clinical familial Alzheimer's disease. Nature Communications. 12: 5346. PMID 34504080 DOI: 10.1038/s41467-021-25492-9   
2021 Kaur D, Behl T, Sehgal A, Singh S, Sharma N, Bungau S. Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies. Neurochemical Research. PMID 34357520 DOI: 10.1007/s11064-021-03415-w   
2021 Tsai HH, Chen YF, Yen RF, Lo YL, Yang KC, Jeng JS, Tsai LK, Chang CF. Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau. Brain : a Journal of Neurology. PMID 34515756 DOI: 10.1093/brain/awab332   
2021 Kumar S, Oh I, Schindler S, Lai AM, Payne PRO, Gupta A. Machine learning for modeling the progression of Alzheimer disease dementia using clinical data: a systematic literature review. Jamia Open. 4: ooab052. PMID 34350389 DOI: 10.1093/jamiaopen/ooab052   
2021 Yu M, Sporns O, Saykin AJ. The human connectome in Alzheimer disease - relationship to biomarkers and genetics. Nature Reviews. Neurology. PMID 34285392 DOI: 10.1038/s41582-021-00529-1   
2021 Cretin B, Bousiges O, Hautecloque G, Philippi N, Blanc F, Dibitonto L, Martin-Hunyadi C, Sellal F. CSF in Epileptic Prodromal Alzheimer's Disease: No Diagnostic Contribution but a Pathophysiological One. Frontiers in Neurology. 12: 623777. PMID 34413819 DOI: 10.3389/fneur.2021.623777   
2021 Latimer CS, Liachko NF. Tau and TDP-43 synergy: a novel therapeutic target for sporadic late-onset Alzheimer's disease. Geroscience. PMID 34185246 DOI: 10.1007/s11357-021-00407-0   
2021 Chong JR, Ashton NJ, Karikari TK, Tanaka T, Schöll M, Zetterberg H, Blennow K, Chen CP, Lai MKP. Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 34510001 DOI: 10.1136/jnnp-2021-327370   
2021 Thijssen EH, La Joie R, Strom A, Fonseca C, Iaccarino L, Wolf A, Spina S, Allen IE, Cobigo Y, Heuer H, VandeVrede L, Proctor NK, Lago AL, Baker S, Sivasankaran R, ... , et al. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. The Lancet. Neurology. 20: 739-752. PMID 34418401 DOI: 10.1016/S1474-4422(21)00214-3